Literature DB >> 2109685

cis-platinum-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450scc in rat testis.

M D Maines1, P M Sluss, M Iscan.   

Abstract

Previously we had shown that cis-platinum decreases testosterone levels in rat serum and that hCG reverses this effect. The purpose of these studies was to determine the biochemical basis of cis-platinum-mediated effects on testicular testosterone production. In the testis of rats treated with cis-platinum (7 mg/kg, iv), the mitochondrial P-450scc concentration and side-chain cleavage activity were depressed by 40%. Also, the microsomal 17 alpha-hydroxylase activity and cytochrome P-450 concentration were decreased. Testicular binding capacity (in vitro) for [125I]hCG was decreased by 75-80%. On the other hand, FSH binding to Sertoli cell membrane receptors was not appreciably changed. hCG (25 IU/100 g daily) in treated rats caused complete occupancy of the remaining 20-25% LH receptors and caused a 20- to 30-fold increase in serum and testicular testosterone, a 2-fold increase in mitochondrial P-450scc, and a 5-fold acceleration of side-chain cleavage activity. 17 alpha-Hydroxylase activity and microsomal cytochrome P-450 were not increased over the control values. In addition to testicular functions, pituitary glycoprotein hormone production was assessed. Treatment of rats with cis-platinum (7 mg/kg, iv) did not change serum LH or FSH, but caused a 50% decrease in serum and testicular testosterone levels. A GnRH challenge test (1.5 micrograms/100 g, in 30 min) of treated rats caused prompt increases of 10- to 15-fold in serum LH and resulted in increases in serum and testicular testosterone. Thus, there was little evidence for cis-platinum effects at the level of hypothalamus or pituitary that could account for the decreased testosterone production. Reversal of the cis-platinum effect on steroidogenesis by hCG or GnRH appears to be due to the induction of suprasaturating levels of LH with full occupancy of remaining Leydig cell LH receptors. This, in turn, would reverse the diminished levels of mitochondrial side-chain cleavage activity and cytochrome P-450scc. These data suggest that cis-platinum causes a depression in serum testosterone, mainly by decreasing the number of LH receptors and inhibiting side-chain cleavage activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109685     DOI: 10.1210/endo-126-5-2398

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner.

Authors:  Shannon D Whirledge; Jose M Garcia; Roy G Smith; Dolores J Lamb
Journal:  Biol Reprod       Date:  2015-01-28       Impact factor: 4.285

2.  Sex-dependent expression and growth hormone regulation of class alpha and class mu glutathione S-transferase mRNAs in adult rat liver.

Authors:  P K Srivastava; D J Waxman
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

3.  Effect of testosterone on Cisplatin-induced nephrotoxicity in surgically castrated rats.

Authors:  Bahar Rostami; Mehdi Nematbakhsh; Zahra Pezeshki; Ardeshir Talebi; Mohammad Reza Sharifi; Fatemeh Moslemi; Fatemeh Eshraghi-Jazi; Farzaneh Ashrafi
Journal:  Nephrourol Mon       Date:  2014-09-05

4.  Endocrinological late effects after chemotherapy for testicular cancer.

Authors:  C C Berger; C Bokemeyer; F Schuppert; H J Schmoll
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

5.  Acacia hydaspica ethyl acetate extract protects against cisplatin-induced DNA damage, oxidative stress and testicular injuries in adult male rats.

Authors:  Tayyaba Afsar; Suhail Razak; Muhammad Rashid Khan; Ali Almajwal
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

6.  Evaluation of the Protective Effect of Olive Leaf Extract on Cisplatin-Induced Testicular Damage in Rats.

Authors:  Rafa S Almeer; Ahmed E Abdel Moneim
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.